PipelineContact Us

Functional antibody screening

BiTAC technology

Events & conferences

Scientific publications

Imprint Privacy policy

Press Release

VERAXA Biotech Launches New BiTAC Platform to Develop Breakthrough Antibody Therapies with Unprecedented Safety Features

BiTACs benefit from novel architecture with combinatorial-gated design for cancer targeting and built-in safety features

VERAXA Biotech Announces Formation of Clinical Advisory Board to Support Expansion of Proprietary Pipeline in Oncology

Board adds profound clinical expertise in oncology as well as expertise across multiple antibody-based therapeutic modalities to VERAXA

VERAXA Biotech Signs Exclusive License Agreement with Cherry Biolabs to Expedite the Development of New Technology Platforms

New IP combined with VERAXA’s deep ADC and antibody expertise to give rise to new therapeutic strategies with unique safety features